At CPHI Frankfurt, Germany October 30, 2025 Conical Pharmaceuticals proudly concludes three inspiring days at CPHI Frankfurt 2025, the world’s leading pharmaceutical exhibition and conference held at Messe Frankfurt from 28–30 October 2025. Present at Booth 4.1C60, Conical represented India as a trusted global manufacturer and exporter of pharmaceutical and nutraceutical products.
Conical Pharmaceuticals Team Highlighted Global Expertise at CPHI Frankfurt 2025
- The Conical Pharmaceuticals delegation made a strong impact at the international exhibition, showcasing the company’s global manufacturing capabilities, diverse product portfolio, and commitment to advancing healthcare with compassion.
- Throughout the event, the team engaged with international partners, explored new opportunities, and built meaningful collaborations that will strengthen Conical’s presence in global markets.
Representing the company were:
Shrikant Maniya – Business Development Head, who led strategic discussions with global stakeholders and highlighted Conical’s export readiness.
Nikunj Maniya, Operations Head, emphasized the company’s GMP‑certified facilities and operational excellence across multiple dosage forms, including tablets, capsules, injections, ointments, granules, and syrups.
Krina Mistry, Business Development Officer, connected with new partners and reinforced Conical’s vision of delivering high‑quality pharmaceutical and nutraceutical solutions worldwide.
Delegates Driving Global Collaborations
Conical Pharmaceuticals’ delegation actively participated in more than 20+ strategic meetings with distributors, regulatory experts, and international stakeholders over the period of the three-day exhibition.
Under the direction of Shrikant Maniya, Nikunj Maniya, and Krina Mistry, the group effectively developed new partnerships, strengthened current ones, and investigated collaborative prospects in a variety of markets.
These interactions not only showed Conical’s GMP-certified capabilities and export readiness, but they also set the stage for long-term partnerships that will speed up the company’s global expansion and impact in the healthcare industry.
Conical Pharmaceuticals Presented a Diverse, Export-Ready Product Portfolio at CPHI Frankfurt 2025
Visitors at Conical’s booth explored a comprehensive portfolio spanning tablets, capsules, syrups, injections, ointments, sachets, powders, gummies, and effervescent tablets. Each product reflects the company’s commitment to quality, compliance, and continuous innovation, reinforcing its reputation as a trusted global supplier.
Spotlight on Hero Products
- Liposomal Tablets & Capsules: Engineered for superior bioavailability and targeted delivery, these drew significant attention from distributors, formulation scientists, and healthcare brands seeking next‑gen solutions.
- Effervescent Tablets: Featuring Vitamin C, Glutathione, and Collagen effervescents, praised for stability, rapid absorption, and consumer‑friendly formats, sparking strong interest for private label, B2B supply, and global distribution.
Advancing Global Market Access Through Strong Regulatory Compliance and International Approvals
Conical Pharmaceuticals continues to lead with a strong regulatory framework backed by international certifications, including WHO‑GMP, US‑FDA (registered facilities/products), Philippines FDA, Ghana FDA/MOH Ghana, PPB Kenya, Jordan FDA, NAFDAC Nigeria, and multiple other global approvals. With exports spanning 15+ countries, Conical remains committed to delivering compliant, effective, and export‑ready healthcare solutions worldwide.
Building Bridges Across Borders
CPHI Frankfurt 2025 was more than an exhibition; it was a milestone. Conical connected with partners who share its vision for accessible global healthcare, explored new markets, and laid the foundation for future collaborations that will drive innovation across the pharmaceutical and nutraceutical landscape.
A notable highlight at CPHI Frankfurt 2025 was the Leadership Summit, where global pharma leaders discussed resilience, AI‑driven drug development, and sustainability in manufacturing. Conical’s participation aligned perfectly with these themes, showcasing our advanced effervescent and liposomal technologies as solutions for faster absorption, patient adherence, and eco‑friendly packaging.
Looking Ahead: Expanding Global Reach After a Successful CPHI Frankfurt 2025
As Conical Pharmaceuticals wraps up a successful showcase at CPHI Frankfurt 2025, we return with renewed energy to expand our international footprint and bring advanced healthcare solutions to even more markets. A heartfelt thank you to everyone who visited us at CPHI Frankfurt 2025 Hall H4.1 | Booth 4.1C60.
We also attended CPHI PMEC 2025 in Delhi, India (November 2025), where we connected with new partners and explored further opportunities in global healthcare.
For global partnerships & dossier specifications,
